|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Celebrex (Celecoxib) Capsules, Pharmacia NDA 20-998/S013 8/29/02 8/30/02 Celebrex Capsules, 100 mg, G. D. Searle & Co. NDA 20-998/S010 10/18/01 11/5/01 11/5/01 Celebrex (celecoxib) Capsules, 100 mg and 200 mg, G.D. Searle L.L.C. NDA 20-998/S9 6/7/02 6/17/02 6/7/02 8/29/02 CELEBREX (celecoxib capsules), 100 mg and 200 mg, G.D. Searle NDA 20-998 12/31/98 1/5/99 1/5/99 6/9/99 Celebrex (Celecoxib) Capsules, Pharmacia NDA 21-156/S1 & S2 8/29/02 8/30/02 Celebrex Capsules, G. D. Searle & Co. NDA 21-156 & 20-998/S007 12/23/99 12/27/99 12/27/99 6/18/01 Celebrex Indication: To reduce the number of adenomatous colorectal polyps in familial adenomatous polyposis (FAP), as an adjunct to usual care (e.g., endoscopic surveillance , surgery). | Celebrex (Celecoxib) Capsules, Pfizer, Labeling Revision | Celebrex (celecoxib) capsules, Pfizer Global Pharma, Labeling Revision | Celebrex (celecoxib) Capsules, Pfizer, New or Modified Indication & Labeling Revision
|